Calls
1
u/Buy-NVDA
Reddit r/wallstreetbets
Win Rate
100.0%
Return
+5.8%
Loading charts...
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
Long
May 11
$16.92
+5.8%
Institutions bought shares at $17.00 in an upsized offering and are locked from selling until $26; stock currently trades at $16.89. This creates a “floor” below the offering price, and the June 30 PDUFA for veligrotug is a binary catalyst that could send the stock to $34+. Buy the dip below institutional entry; the setup offers both downside protection (institutional floor) and upside optionality (FDA approval). FDA denial or delay on June 30; negative clinical or safety readouts; broader biotech selloff; dilution risk from the convertible notes (conversion at $24.65).
Institutions bought shares at $17.00 in an upsized offering and are locked from selling until $26; stock currently trades at $16.89. This creates a “floor” below the offering price, and the June 30 PDUFA for veligrotug is a binary catalyst that could send the stock to $34+. Buy the dip below institutional entry; the setup offers both downside protection (institutional floor) and upside optionality (FDA approval). FDA denial or delay on June 30; negative clinical or safety readouts; broader biotech selloff; dilution risk from the convertible notes (conversion at $24.65).
Healthcare
Showing 1 of 1 picks · sorted by mentions
Choose a mentions count to open ticker posts.
u/Buy-NVDA has 1 trade idea tracked on Buzzberg across 1 ticker since May 2026. Most covered: VRDN.
